FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)

Links shared publicly online about this topic.

  • 1,420
    total visits

FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)

fda.gov —

[01-29-2010] the u.s. food and drug administration (fda) is alerting healthcare professionals and patients about a rare, but serious, complication in the liver known as non-cirrhotic portal hypertension in patients using videx or videx ec (didanosine).

View full resource at fda.gov

Tags: High Blood Pressure, Liver, HIV Medication, Disease and Condition, Drug, Healthcare, FDA, Videx

  • Share

Most Recently Shared on February 1, 2010 at 6:38 pm By:

RitaRubin RitaRubin

FDA: Rare but serious liver disorder linked to Videx, an HIV drug. In some, tho, benefits still outweigh risks http://bit.ly/9DBr7t #pharma

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

FiercePharma FiercePharma

Advertisement